Coya Therapeutics, Inc. Common Stock (COYA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $70.37M
Last updated: Nov 17, 2026 at 4:10 PM ET
Coya Therapeutics, Inc. Common Stock (COYA) Stock Chart
Coya Therapeutics, Inc. Common Stock (COYA) has a latest price of $3.02 on Nov 17, 2026, 54.4% below its 52-week high of $6.62. Its price fell 48.6% over the past 12 months. The month-end price fell 23.5% over the 3 years through Oct 2026, a compound annual decline of 8.5%.
Price Chart
From Dec 2022 to Oct 2026, its highest month-end close was $9.92 in Mar 2024 and its lowest $3.53 in Aug 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart COYA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for COYA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 39.2%, and over 6 months it fell 33.9%.
| Period | Change |
|---|---|
| 1 month | -28.1% |
| 3 months | -39.2% |
| 6 months | -33.9% |
| 12 months | -48.6% |
| 12 months, with dividends | -48.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -23.5% | -8.5% |
Price by Year
Its best calendar year was 2023, when the price rose 56.4%, and its weakest was 2024, when it fell 22.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.61 | -37.8% |
| 2025 | $5.80 | +1.2% |
| 2024 | $5.73 | -22.7% |
| 2023 | $7.41 | +56.4% |
Trading Range
The price is 28.5% below its 50-day average of $4.23 and 33.7% below its 200-day average of $4.55.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.02 | |
| 52-week high | $6.62 | -54.4% |
| 52-week low | $2.72 | +11.0% |
| 50-day average | $4.23 | -28.5% |
| 200-day average | $4.55 | -33.7% |
Price Risk
Over 3 years, its largest fall from a peak was 72.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.83 |
| Largest fall, 1 year | -56.8% |
| Largest fall, 3 years | -72.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About COYA
What is COYA's 1-year price change?
Coya Therapeutics, Inc. Common Stock's price fell 48.6% over the past 12 months. With dividends included, the 12-month total return was -48.6%.
How has COYA stock done over the long term?
Coya Therapeutics, Inc. Common Stock's month-end price fell 23.5% over the 3 years through Oct 2026, a compound annual decline of 8.5%. These figures leave out dividends.
What is COYA's 52-week high and low?
Coya Therapeutics, Inc. Common Stock's 52-week high is $6.62 and its 52-week low is $2.72. Its latest price of $3.02 on Nov 17, 2026 is 54.4% below the high.
What is COYA's beta?
Coya Therapeutics, Inc. Common Stock's 1-year beta against the S&P 500 is 1.83, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 56.8%.
Is the COYA chart free?
Yes. Advanced Charting for COYA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
COYA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors